Online weight loss treatment in New York
Surfbound connects eligible adults in New York with licensed providers for online GLP-1 weight-loss treatment review. Semaglutide $169/mo and tirzepatide $219/mo. Prescriptions are not guaranteed and are issued only when medically appropriate.
No in-person visit. A licensed provider reviews your intake. A prescription is not guaranteed.
Can I start online GLP-1 weight loss treatment in New York?
Yes. Eligible adults across New York can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. A licensed provider credentialed in New York reviews your health intake and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your New York address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
The Empire State · Northeast region. NYC density versus upstate rural gaps, with rigorous medical practice standards. Works from NYC to upstate New York online.
Coverage across New York
Surfbound lists 9 New York cities with a dedicated local page. Care is delivered online, so you can also start from anywhere else in the state.
Provider access & processPricing and insurance
Semaglutide is $169/mo and tirzepatide is $219/mo. Clear pricing shown before checkout. Surfbound does not accept insurance at this time.
Shipping to New York
After provider approval, a licensed compounding pharmacy prepares and dispatches the order. For New York addresses, from New York City, Buffalo, Rochester to smaller communities, transit time depends on distance from the dispensing pharmacy, the pharmacy's processing day, weekends and carrier volume — tracking is emailed once the package is with the carrier.
What's included in every New York plan
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. There is no separate membership fee.
New York coverage & access
Practical answers about where you can start, how shipping works, and how to compare complete costs in New York. The New York provider access & process page covers the clinical steps in detail.
Surfbound lists 9 New York cities with a dedicated local page. Because care is delivered online, you can start from anywhere in New York — the city list is a navigation aid, not a limit on where you can begin.
The New York telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in New York. You complete a health intake online, and a licensed provider credentialed in New York reviews your information remotely.
New York permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in New York may review a New York patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in New York” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active New York license issued by the New York State Education Department Office of the Professions, and any pharmacy filling your prescription must be licensed in New York. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in New York” section on this page.
Compounded semaglutide is $169/mo and compounded tirzepatide is $219/mo for New York patients, with the provider review included and no separate membership fee. Pricing is shown before checkout, and compounded medications are not FDA-approved.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
Not guaranteed anywhere in New York. The New York-licensed provider can approve, request more information, or decline after reading your intake.
Switching to Surfbound is possible across New York. Enter your current medication and dose in the doctor-notes field; the New York-licensed provider decides whether to continue at that dose or adjust it, and no written quote is needed.
For New York patients, the honest comparison is all-in monthly cost at the same dose. The GLP-1 total-cost calculator normalises membership, shipping and titration fees against one flat published rate.
Patients in New York can be reviewed for compounded semaglutide. The review, the medication if prescribed, and delivery are covered by one published monthly price. Compounded semaglutide is not FDA-approved.
Yes. Compounded tirzepatide — a dual GIP/GLP-1 receptor agonist — is offered across New York at a flat monthly rate with no dose-based upcharge. A New York-licensed provider determines whether it is medically appropriate, and the pharmacy ships if prescribed. It is not FDA-approved.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and New York residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the New York-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in New York. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed New York provider approves your medication. NYC density versus upstate rural gaps, with rigorous medical practice standards.
Yes. New York residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed New York provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across New York with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. A New York-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. From the Northeast region, New York residents can complete the whole process online: a short intake, a remote review by a New York-licensed provider, and discreet shipping if treatment is prescribed. Works from NYC to upstate New York online.
Yes. Men across New York begin with a private online intake, a licensed New York provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches New York residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Telehealth rules in New York
What governs a provider treating a New York patient online, and where you can check it yourself.
State medical board
New York State Education Department Office of the ProfessionsNew York State Education Department Office of the Professions licenses the providers who review New York intakes. The board site carries the current licensing and practice requirements.
Telehealth statute or rule
New York Education Law Article 131 and Public Health LawOpens the official New York code. Search the statute or rule named above for the full text rather than relying on any summary.
Licensure requirement
A clinician must hold an active New York license to evaluate or treat a patient who is physically located in New York. Every New York intake is routed to a provider credentialed in New York, and a prescription is issued only when that provider determines treatment is medically appropriate.
New York permits telemedicine prescribing when a proper provider-patient relationship has been established. The state has specific requirements for medical records documentation, which Surfbound providers follow for all New York residents.
Surfbound is an online service. We do not have physical offices in New York. Licensed providers review health information online. A prescription is not guaranteed.
Medical sources & references
Surfbound providers are licensed to practice in New York and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official New York state government agency. Provider licensure in New York is governed by the New York State Education Department Office of the Professions.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.